>

BPIFrance Investissement SAS invested in TargEDys SA

Mar 25, 2017 - RelSci Data Update
Investments

Background Information:
BPIfrance Investissement is an active manager focused on small, medium and intermdiate-sized businesses with high-growth potential. They favor sectors related to industry and technology and focus on investments in France.The firm invests either directly through dedicated investment funds or indirectly through private equity funds, partnerships and fund of funds managed by third parties. They invest across development stages, from start-ups to small LBO operations resulting from corporate succession issues. Their deal-sourcing process is both regional and national.
In The News:
Sangamo Therapeutics: Communiqué Normé Related to the Offeror's Draft Prospectus Related to the Simplified Public Tender Offer Targeting the Shares of the Company
October 2, 2018  •  Business Wire
BPIFrance Investissement SAS invested in EasyMile SAS
September 22, 2018  •  RelSci
Electric Vehicle Charging Solutions : Total Acquires G2mobility and Forms Partnership with Nexans
September 20, 2018  •  Business Wire
BPIfrance Investissement is an active manager focused on small, medium and intermdiate-sized businesses with high-growth potential. They favor sectors related to industry and technology and focus on investments in France.The firm invests either directly through dedicated investment funds or indirectly through private equity funds, partnerships and fund of funds managed by third parties. They invest across development stages, from start-ups to small LBO operations resulting from corporate succession issues. Their deal-sourcing process is both regional and national.
TargEDys SA develops microbiome-based solutions for appetite regulation. It provides humanity with easy means of regulating their eating behaviors for the third millennium. The company was founded by Pierre Dechelotte and Gregory Lambert 2011 and is headquartered in Paris, France.
In The News:
Philippe Lavielle is now serving in a new board position at TargEDys SA
July 8, 2018  •  RelSci
TargEDys grabs funding
April 11, 2017  •  peHUB
TargEDys Extends Series A and Appoints New Board Members
April 11, 2017  •  PR Newswire
TargEDys SA develops microbiome-based solutions for appetite regulation. It provides humanity with easy means of regulating their eating behaviors for the third millennium. The company was founded by Pierre Dechelotte and Gregory Lambert 2011 and is headquartered in Paris, France.
In The News:
 April 11, 2017  •  peHUB